Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remis... (original ) (raw )Low-Dose Total-Body Irradiation and Fludarabine Followed by Hematopoietic Cell Transplantation From HLA-Identical Sibling Donors Do Not Induce Complete T-Cell Donor …
Carmen martínez
Experimental …, 2003
View PDFchevron_right
Feasibility of reduced intensity hematopoietic stem cell transplantation from an HLA-matched unrelated donor
M Kami
2004
View PDFchevron_right
Low-Dose Total Body Irradiation and Fludarabine Conditioning for HLA Class I-Mismatched Donor Stem Cell Transplantation and Immunologic Recovery in Patients with Hematologic Malignancies: A Multicenter Trial
James Wade
Biology of Blood and Marrow Transplantation, 2010
View PDFchevron_right
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies
john slattery
View PDFchevron_right
LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-, HLA-B-, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES1
Tina Dalianis
Transplantation, 1998
View PDFchevron_right
Transplantation of HLA-mismatched CD34+ selected cells in patients with advanced malignancies: severe immunodeficiency and related complications
N. Mordini
British Journal of Haematology, 1997
View PDFchevron_right
Marrow transplantation from HLA non-identical family donors for the treatment of leukaemia: a pilot study of 15 patients using additional immunosuppression and T-cell depletion
Philippe Montcuquet
British Journal of Haematology, 2008
View PDFchevron_right
Complete donor chimerism following 0/10 HLA-mismatched unrelated donor allogeneic hematopoietic stem cell transplantation
Marianne Hokland
Bone Marrow Transplantation
View PDFchevron_right
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities
Michael Maris
Blood, 2004
View PDFchevron_right
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia
Michael Maris
Biology of Blood and Marrow Transplantation, 2005
View PDFchevron_right
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning …
Richard Maziarz
Biology of Blood and …, 2008
View PDFchevron_right
Unrelated Donor Hematopoietic Cell Transplantation: Factors Associated with a Better HLA Match
Arturo Molina , Koen van Besien
Biology of Blood and Marrow Transplantation, 2008
View PDFchevron_right
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT
Denis-claude Roy
Haematologica
View PDFchevron_right
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors
Boris Fehse
Experimental Hematology, 2008
View PDFchevron_right
Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders
Michael Loken
Bone Marrow Transplantation, 2007
View PDFchevron_right
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
Mary Leffell
Biology of Blood and Marrow Transplantation, 2002
View PDFchevron_right
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts
John Wingard
Blood, 2011
View PDFchevron_right
Donor Age and Degree of Hla Matching Have a Major Impact on the Outcome of Unrelated Haematopoietic Cell …
C. Canizo
View PDFchevron_right
Reduced-Intensity Allogeneic Transplantation Using Alemtuzumab from HLA-Matched Related, Unrelated, or Haploidentical Related Donors for Patients with Hematologic Malignancies
Stephen Schey
Biology of Blood and Marrow Transplantation, 2014
View PDFchevron_right
HLA-Matched Related Donor Hematopoietic Cell Transplantation in 43 Patients with Fanconi Anemia Conditioned with 60 mg/kg of Cyclophosphamide
Marco Bitencourt , Vaneuza Funke
Biology of Blood and Marrow Transplantation, 2007
View PDFchevron_right
Novel strategies for adoptive therapy following HLA disparate transplants
Aisha Hasan
Best Practice & Research Clinical Haematology, 2011
View PDFchevron_right
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors
Brenda Sandmaier
Blood, 2004
View PDFchevron_right
16th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation
Eric Spierings , Anne Cesbron
International Journal of Immunogenetics, 2012
View PDFchevron_right
Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants
ISABEL Cunningham
Blood, 1989
View PDFchevron_right
6th IHIW: International Histocompatibility Working Group in Hematopoietic Cell Transplantation
Eric Spierings
View PDFchevron_right
Bone marrow as stem cell source for allogeneic HLA-identical sibling transplantation following reduced-intensity preparative regimen
Daniel Olive
Experimental Hematology, 2003
View PDFchevron_right
Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus
Jack Singer
Blood, 1993
View PDFchevron_right
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioning
R. Hough
Blood, 2010
View PDFchevron_right
Using Related Donors other Than Genotypically HLA-Matched Siblings in Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Disease: A Single Institution Experience in Japan
Shigetaka Asano , Satoshi Takahashi
International Journal of Hematology, 2002
View PDFchevron_right
Marrow transplants from unrelated donors for patients with aplastic anemia: Minimum effective dose of total body irradiation
Michael Amylon
Biology of Blood and Marrow Transplantation, 2001
View PDFchevron_right